Breast cancer is a lethal illness that has a high mortality rate. In treatment, the accuracy of diagnosis is crucial. Machine learning and deep learning may be beneficial to doctors. The proposed backbone network is critical for the present performance of CNN-based detectors. Integrating dilated convolution, ResNet, and Alexnet increases detection performance. The composite dilated backbone network (CDBN) is an innovative method for integrating many identical backbones into a single robust backbone. Hence, CDBN uses the lead backbone feature maps to identify objects. It feeds high-level output features from previous backbones into the next backbone in a stepwise way. We show that most contemporary detectors can easily include CDBN to improve performance achieved mAP improvements ranging from 1.5 to 3.0 percent on the breast cancer histopathological image classification (BreakHis) dataset. Experiments have also shown that instance segmentation may be improved. In the BreakHis dataset, CDBN enhances the baseline detector cascade mask R-CNN (mAP = 53.3). The proposed CDBN detector does not need pretraining. It creates high-level traits by combining low-level elements. This network is made up of several identical backbones that are linked together. The composite dilated backbone considers the linked backbones CDBN.
2
4 October 2023 in Multimedia Tools and Applications
Most approaches use interactive priors to find tumours and then segment them based on tumour-centric candidates. A fully convolutional network is demonstrated for end-to-end breast tumour segmentation. When confronted with such a variety of options, to enhance tumour detection in digital mammograms, one uses multiscale picture information. Enhanced segmentation precision. The sampling of convolution layers are carefully chosen without adding parameters to prevent overfitting. The loss function is tuned to the tumor pixel fraction during training. Several studies have shown that the recommended method is effective. Tumour segmentation is automated for a variety of tumour sizes and forms postprocessing. Due to an increase in malignant cases, fundamental IoT malignant detection and family categorisation methodologies have been put to the test. In this paper, a novel malignant detection and family categorisation model based on the improved stochastic channel attention of convolutional neural networks (CNNs) is presented. The lightweight deep learning model complies with tougher execution, training, and energy limits in practice. The improved stochastic channel attention and DenseNet models are employed to identify malignant cells, followed by family classification. On our datasets, the proposed model detects malignant cells with 99.3 percent accuracy and family categorisation with 98.5 percent accuracy. The model can detect and classify malignancy.
Glaucoma is prominent in a variety of nations, with the United States and Europe being two of the most famous. Glaucoma now affects around 78 million people throughout the world (2020). By the year 2040, it is expected that there will be 111.8 million cases of glaucoma worldwide. In countries that are still building enough healthcare infrastructure to cope with glaucoma, the ailment is misdiagnosed nine times out of ten. To aid in the early diagnosis of glaucoma, the creation of a detection system is necessary. In this work, the researchers propose using a technology known as deep learning to identify and predict glaucoma before symptoms appear. The glaucoma dataset is used in this deep learning algorithm that has been proposed for analyzing glaucoma images. To get the required results when using deep learning principles for the job of segmenting the optic cup, pretrained transfer learning models are integrated with the U-Net architecture. For feature extraction, the DenseNet-201 deep convolution neural network (DCNN) is used. The DCNN approach is used to determine whether a person has glaucoma. The fundamental goal of this line of research is to recognize glaucoma in retinal fundus images, which will aid in assessing whether a patient has the condition. Because glaucoma can affect the model in both positive and negative ways, the model’s outcome might be either positive or negative. Accuracy, precision, recall, specificity, the F-measure, and the F-score are some of the metrics used in the model evaluation process. An extra comparison study is performed as part of the process of establishing whether the suggested model is accurate. The findings are compared to convolution neural network classification methods based on deep learning. When used for training, the suggested model has an accuracy of 98.82 percent and an accuracy of 96.90 percent when used for testing. All assessments show that the new paradigm that has been proposed is more successful than the one that is currently in use.